2-(2-Chloropyridin-3-yl)-1-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazole

Catalog No. :
ACGWEM445
CAS No. :
338411-25-9
Molecular Formula :
C19H13ClFN3
Molecular Weight :
337.79

IUPAC Name:2-(2-chloropyridin-3-yl)-1-(2-fluorobenzyl)-1H-benzo[d]imidazole

2-(2-Chloropyridin-3-yl)-1-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloropyridin-3-yl)-1-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazole
IUPAC Name2-(2-chloropyridin-3-yl)-1-(2-fluorobenzyl)-1H-benzo[d]imidazole
MDL No.MFCD00244051
Molecular FormulaC19H13ClFN3
Molecular Weight337.79
SMILESFC1=CC=CC=C1CN2C(C3=CC=CN=C3Cl)=NC4=CC=CC=C42
InChI KeyDOUXLIDMBKYMCM-UHFFFAOYSA-N
Synonym2-(2-CHLORO-3-PYRIDINYL)-1-(2-FLUOROBENZYL)-1H-1,3-BENZIMIDAZOLE;2-(2-chloropyridin-3-yl)-1-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazole;1H-Benzimidazole, 2-(2-chloro-3-pyridinyl)-1-[(2-fluorophenyl)methyl]-
CAS No.338411-25-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGWEM445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGWEM445 route product structure diagram
    ACGWEM445338411-25-9
Inquiry

2. ACGWEM445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGWEM445 route product structure diagram
    ACGWEM445338411-25-9
Inquiry

Comments (0)